MIRA INFORM
REPORT
|
Report Date : |
16.06.2011 |
IDENTIFICATION DETAILS
|
Correct Name : |
FRATER LABORATOIRES SARL |
|
|
|
|
Registered Office : |
51 Rue Keddour
Lazergui Saoula Alger Algerie |
|
|
|
|
Country : |
Algeria |
|
|
|
|
Date of Incorporation : |
06.01.2004 |
|
|
|
|
Com. Reg. No.: |
04B0967348 |
|
|
|
|
Legal Form : |
Societe Anonyme
Responsabilite Limitee. |
|
|
|
|
Line of Business : |
dealers in pharmaceutical products and related
products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 80,000 |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Algeria |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Bottom of Form
SUBJECT'S NAME
Registered Name: FRATER LABORATOIRES SARL
Requested Name: SARL
FRATER LABORATOIRES
Other Names: None
ADDRESS AND TELECOMMUNICATION
Physical Address: 51
Rue Keddour Lazergui Saoula Alger Algerie
Postal Address: 51
Rue Keddour Lazergui Saoula
Alger Algerie
Country: Algeria
Phone: 213-21-557753/
356690/ 299160/ 9280/ 9489/ 98
Fax: 213-21-557694/
356694/ 999488
Email: contact@frater-razes.com
Website: www.frater-razes.com
CREDIT OPINION
Financial Index as of December 2010 shows subject firm with a medium
risk of credit. However, bank and credit information obtained reveal a history
of prompt payments. We recommend Credit of USD 80,000 on 90 days.
LEGAL
Legal Form: Societe Anonyme Responsabilite Limitee.
Date Incorporated: 6-Jan-2004
Reg. Number: 04B0967348
Nominal Capital DZD. 240,000,000
Subscribed Capital DZD. 240,000,000
Subscribed Capital is Subscribed in the following form:
Position Shares
Dr. Abdelhamid
Cherfaoui Chairman/ CEO
Mr. Fateh Cherfaoui Director
Mr. Salem
Cherfaoui Director
Mr. Embarek
Cherfaoui Director
Frater-Razes
Laboratories Holding Company 100%
RELATED COMPANIES
Frater-Razes
Laboratories Parent company.
None Subsidiary company.
PROVIVO,
RAZES LABORATORIES,
SOME PHARM. Affiliated company.
None Shareholder of subject firm.
None Branches of the firm
OPERATIONS
Registered to operate as dealers in pharmaceutical products and related
products
Imports: ASia
Exports: None
Trademarks: None
Terms of sale: Cash
(40%) and 30 days (60%), invoices.
Main Customers: firms
and organizations
Employees: 30
employees.
Vehicles: Several
motor vehicles.
Territory of
sales: Algeria
Location: Rented
premises, 5.000 square feet,
AUDITORS AND INSURANCE
Auditors: Information not available.
Insurance
Brokers: Information not available.
FINANCE
Currency Reported: Algerian Dinar (DZD.)
Approx. Ex. Rate: 1 US Dollar = 71.85 Algerian Dinar
Fiscal
Year End: December 31, 2010
Inflation: According to
information given by independent sources, the
inflation
at December 31st, 2010 was of 13%.
Financial Information not Submitted
Profit and Loss (expressed in DZD.)
2010
Sales 450,000,000
BANK
Bank Name: El Khalifa Bank
Branch: Algiers
Comments: None
TRADE
REFERENCES
Experiences: Good
NOTARIAL
BONDS
None
COMMENTS / ADDITIONAL INFORMATION
This information was obtained from outside sources other than the
subject company itself and confirmed the above subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.68 |
|
UK Pound |
1 |
Rs.73.05 |
|
Euro |
1 |
Rs.64.29 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.